Dr. Jennifer L. Kirby, associate professor in the Division of Endocrinology and Metabolism at UVA Health, commented that “The data is pretty impressive. We have a limited amount of tools in our toolbox when it comes to the treatment of overweight and obesity. The addition of semaglutide is excellent news.”